Momenta (MNTA) Shares Surge 12 percent

Momenta Pharmaceuticals, Inc. (MNTA) stock is exploding higher by more than 12% Thursday after the company announced that the FDA granted approval of ANDA for Glatopa(TM) (glatiramer acetate injection), the first substitutable generic for COPAXONE(R) (glatiramer acetate injection) 20mg. “We are proud to be able to offer patients with multiple sclerosis the first generic version […] View the full post at: Momenta (MNTA) Shares Surge 12 percent Related posts: Atlas Pipeline (APL) Shares Soar On Nat Gas Asset Sale Broadcom Gaining Ground In Smartphone Market, Shares May See 40% Upside